Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
about
Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.PARP inhibition and synthetic lethality in ovarian cancer.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells
P2860
Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
@en
type
label
Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
@en
prefLabel
Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
@en
P2093
P2860
P1476
Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
@en
P2093
James Cripe
Ramez N Eskander
Robert E Bristow
P2860
P2888
P356
10.1007/S11864-013-0264-2
P577
2014-03-01T00:00:00Z
P6179
1006145839